| Trustee name | Office (ifany) | Dates acted if not for whole ear |
||
|---|---|---|---|---|
| Ann Beasley | Chair | |||
| Vanessa Ford | Acting Chief Executive | Until September 2020 | ||
| Chief Executive | Since September 2020 | |||
| Philip Murray | Director ofFinance and | Performance | ||
| Sharon Spain | Acting Director of |
Nursing | and | Until November 2020 |
| Quality Standards | ||||
| Director of Nursing |
and | Quality | Since November 2020 | |
| Standards | ||||
| Dr Charlotte Harrison |
Acting Medical Director | Until March 2021 | ||
| Dr Billy Boland | Medical Director | Since March 2021 | ||
| Ranjeet Kaile | Director of Communications |
and | Until February 2021 | |
| Stakeholder Engagement |
||||
| Jennifer Allan | Chief Operating Officer |
|||
| Amy Scammell | Director ofStrategy and Commercial | |||
| Development | ||||
| Richard Flatman |
Non-Executive Director |
|||
| Jean Daintith | Non-Executive Director |
|||
| Sola Afuape | Non-Executive Director |
|||
| Juliet Armstrong | Non-Executive Director |
|||
| Vikas Sagar | Non-Executive Director |
|||
| Doreen McCollin | Non-Executive Director |
|||
| Deborah Bowman |
Non-Executive Director |
| Total | Total | |||||
|---|---|---|---|---|---|---|
| Note | Unrestricted Funds |
Restricted Funds |
Funds | Funds | ||
| 2021 | 2020 | |||||
| E'000 | E'000 | F'000 | E'000 | |||
| Income and endowments | from: | |||||
| Donations and legacies |
119 | 119 | ||||
| Charitable activities |
||||||
| Other trading activities |
||||||
| Investments | ||||||
| Total incoming resources | 120 | 121 | ||||
| Expenditure on: |
||||||
| Charitable activities |
||||||
| Admin and Audit fees | (12) | (12) | (8) | |||
| Patients comfort 8 other |
(35) | (35) | (36) | |||
| Staff welfare | (34) | (34) | (6) | |||
| (81) | (81) | (50) | ||||
| Total expenditure | (81) | (81) | (50) | |||
| Net gains/(losses) on investments |
15 | (2) | ||||
| Net income/(expenditure) | 39 | 40 | (43) | |||
| Transfers between funds |
||||||
| Net Movement in funds |
39 | 40 | (43) | |||
| Reconciliation ofFunds |
||||||
| Total Funds brought forward |
20 | 37 | 17 | 54 | 97 | |
| Total Funds carried forward | 20 | 18 | 94 | 54 |
| Unrestricted | Restricted | Total | Total | ||
|---|---|---|---|---|---|
| Note | |||||
| Funds | Funds | Funds | Funds | ||
| 2021 | 2020 | ||||
| f.'000 | f'000 | E'000 | |||
| Fixed assets: | |||||
| Investments | 23 | 16 | 39 | 81 | |
| Total Fixed Assets | 23 | 16 | 39 | 81 | |
| Current assets: | |||||
| Debtors | 16 | ||||
| Cash and cash equivalents | 17 | 177 | 179 | 34 | |
| Total Current Assets | 177 | 179 | 34 | ||
| Liabilities: | |||||
| Creditors falling due within one year |
18 | (124) | (124) | (61) | |
| Net Current assetsl(liabilities) |
53 | 55 | (27) | ||
| Total assets less current liabilities |
76 | 18 | 94 | 54 | |
| Creditors falling due after more than one year |
18 | ||||
| Total net assets or liabilities |
76 | 18 | 94 | 54 | |
| The funds ofthe Charity: | 20 | ||||
| Restricted income funds |
18 | 18 | 17 | ||
| Unrestricted income funds |
76 | 76 | 37 | ||
| Total Charity funds | 76 | 18 | 94 | 54 |
| Note | Total | Total | |||||
|---|---|---|---|---|---|---|---|
| funds | funds | ||||||
| 2021 | 2020 | ||||||
| f'000 | F'000 | ||||||
| Cash flows from operating | activities: | ||||||
| Net cash provided by (used in) operating | activities | 19 | 143 | (9) | |||
| Cash flows from investing | activities: | ||||||
| Dividends, interest and rents |
from investments | 6 | |||||
| Proceeds from the sale of investments | 19 | ||||||
| Purchase ofinvestments | 19 | ||||||
| Net cash provided by (used in)investing | activities | ||||||
| Change in cash and cash period |
equivalents | in the reporting | 145 | (6) | |||
| Gash and cash equivalents at the reporting period |
beginning | of the | 34 | 4Q | |||
| Cash and cash equivalents period |
at the end | of the reporting | 179 | 34 |
| Unrestricted | Restricted | Total | Total | ||
|---|---|---|---|---|---|
| funds | Funds | 2021 | 2020 | ||
| F'000 | K'000 | E'000 | f.'000 | ||
| NHS Charities Together | 100 | 100 | |||
| Donations | from individuals | ||||
| Corporate | donations | ||||
| Legacies | |||||
| Grants | |||||
| Total | 119 | 119 |
| Unrestricted | Restricted | Total | Total | ||||
|---|---|---|---|---|---|---|---|
| funds | funds | 2021 | 2020 | ||||
| K'000 | K'000 | K'000 | K'000 | ||||
| Fixed Asset | Equity | and | similar | ||||
| investments | |||||||
| Short term |
Investments | 8 | |||||
| deposits 8 cash on | deposit |
| Grant funded | Support | Total | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Activity | Costs | 2021 | 2020 | |||||
| f.'000 | f.'000 | R'000 | F'000 | |||||
| Patients other |
comfort, | functions | 8 | 35 | 41 | 40 | ||
| Staff education | and | welfare | 34 | 40 | 10 | |||
| Total | 69 | 12 | 81 | 50 |
| Raising funds |
Charitable activities |
2021 T t i o al |
2020 Total |
Basis | |||
|---|---|---|---|---|---|---|---|
| F'000 | E'000 | R'000 | E'000 | ||||
| Independent | Examination | 2 | 2 | 2 | Expenditure | ||
| Accountancy | Costs | Expenditure | |||||
| Staff salary | recharges | 10 | 10 | 6 | Expenditure | ||
| Governance | costs | 12 | 12 | ||||
| Office Admin | Charge | ||||||
| Total | 12 | 12 | |||||
| Unrestricted funds |
Restricted funds |
Endowment funds |
2020 | ||||
| Total | Total | ||||||
| R'000 | R'000 | R'000 | R'000 | R'000 | |||
| Charitable | Activities | 12 | 12 | 8 | |||
| 12 | 12 | 8 |
| 16. Analysis of | current debtors | ||
|---|---|---|---|
| Debtors under | 1year | 2021 | 2020 |
| f.000 | OOOO | ||
| Accrued income | |||
| Total | |||
| 17. Analysis of | cash and cash equivalents | ||
| 2021 | 2020 | ||
| f000 | f000 | ||
| Cashin hand | 1 | 1 | |
| Current Account | 178 | 33 | |
| Total cash and | cash equivalents | 179 | 34 |
| No cash orcash equivalents | orcurrent asset investments | orcurrent asset investments | orcurrent asset investments | orcurrent asset investments | were held in non-cash investments | were held in non-cash investments | were held in non-cash investments | were held in non-cash investments | oroutside | |
|---|---|---|---|---|---|---|---|---|---|---|
| ofthe UK. AII ofthe amounts | held in the current | account | are | available to spend on | charitable | activities. | ||||
| 18. Analysis ofliabilities |
||||||||||
| 2021 | 2020 | |||||||||
| f000 | OOOO | |||||||||
| Creditors under 1year |
||||||||||
| Trade creditors | 10 | 10 | ||||||||
| Other accruals | 114 | 51 | ||||||||
| 124 | 61 | |||||||||
| Creditors falling due | after more than | 1year | ||||||||
| Total | 124 | |||||||||
| 19. Reconciliation of |
net income/(expenditure) |
to net cash | flow | from | operating | |||||
| activities | ||||||||||
| 2021 | 2020 | |||||||||
| 6'000 | F'000 | |||||||||
| Net incomel(expenditure) (as Statement ofFinancial Activities) |
per | the | 40 | (43) | ||||||
| Adjustments for: |
||||||||||
| (Gains)/losses on investments |
||||||||||
| (Purchase)/Sale of Investments |
42 | |||||||||
| Dividends, interest and |
rents from investments | (2) | (3) | |||||||
| (Increase)/decrease | in | debtors | ||||||||
| Increase/(decrease) | in | creditors | 63 | 35 | ||||||
| Net cash provided activities |
by (used in) | operating | 143 | (9) |
| Balance | Income | Expenditure | Transfers | Balance | ||
|---|---|---|---|---|---|---|
| b/f | Gains/Losses | c/f | ||||
| K'000 | F'000 | K'000 | R'000 | E'000 | ||
| Child Psychiatry | 2 | 2 | ||||
| Henderson Staff Training |
2 | 2 | ||||
| Sutton Community |
Older | 1 | 1 | |||
| People fund | ||||||
| Crocus ward | 10 | |||||
| Others (below 71k) | 3 | |||||
| Total | 17 | 18 |
| Balance b/f |
Income | Expenditure | Transfers Gains/ Losses |
Balance c/f |
||||
|---|---|---|---|---|---|---|---|---|
| K'000 | E'000 | 8,'000 | K'000 | E'000 | ||||
| Aquarius | 9 | 9 | ||||||
| Deaf 8 Family | ||||||||
| contingency | ||||||||
| Pharmacy | MHU | |||||||
| Richmond | Comm. | MH | ||||||
| team | ||||||||
| Other designated | funds | 12 | ||||||
| General fund | (81) | 40 | ||||||
| Total | 37 | 120 | (81) | 76 |